We are live on ! Find out more
ZIVOW

Zivo Bioscience, Inc. Warrants
ZIVOW

Delisted

ZIVOW was delisted on the 24th of November, 2023.

Back to rankings

5 hedge funds and large institutions have $62K invested in Zivo Bioscience, Inc. Warrants in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

6% less capital invested

Capital invested by funds: $66K → $62K (-$4K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$202

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$7.11K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Ayrton Capital
Connecticut
$36K – – –
CH
2
CVI Holdings
Delaware
$11K – – –
WAM
3
Warberg Asset Management
Illinois
$9K -$7.11K -10,560 -40%
VCA
4
Verdence Capital Advisors
Maryland
$4K – – –
UBS Group
5
UBS Group
Switzerland
$2K +$202 +300 +9%

ZIVOW Hedge Fund Activity: Q2 2022 in Review

5 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q2 2022, worth a combined $62K — down 6.1% from $66K a quarter earlier.

Fund positioning in ZIVOW was balanced in Q2 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $202. The largest seller was Warberg Asset Management, cutting an estimated $7.11K.

  • 5 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $62K of Zivo Bioscience, Inc. Warrants stock for Q2 2022, down 6.1% quarter-over-quarter.
  • 0 funds opened new Zivo Bioscience, Inc. Warrants positions in Q2 2022 and 0 closed out.
  • The largest Zivo Bioscience, Inc. Warrants buyer in Q2 2022 was UBS Group, an estimated $202 added.
  • The largest Zivo Bioscience, Inc. Warrants seller in Q2 2022 was Warberg Asset Management, an estimated $7.11K sold.

Based on aggregated 13F filings for Q2 2022.